SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the third quarter ended September ...

NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic ...

The gene-therapy biotech Bluebird Bio announced plans on Tuesday to slash its budget and headcount. The Massachusetts biotech previously warned investors about "substantial doubt" about its future.

Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24 ...

Engineered viruses are the delivery vehicle of choice for many genetic medicines, but they pose several problems. In addition to the risk of dangerous immune responses, these viruses don’t go to all ...

Rejuvenate Bio is a gene therapy startup that seeks to reverse aging. In response to emailed questions, CEO and Co-founder Daniel Oliver talked about how he and his co-founder started the company and ...

CAMBRIDGE, MA: Senior research associate Lauryn Christiansen works on lentiviral gene delivery into stem cells. The work is for the treatment of ALD, Thalassemia and Sickle Cell Anemia. Bluebird bio, ...

A confluence of advances in biological sciences with the accelerating development of engineering, computing, materials science, automation, and artificial intelligence, is fueling a new wave of ...

Hollywood apocalypses come in all shapes and sizes – zombified, post-nuclear, plague-ridden – so it says something that the European eco-fable Vesper can weave together strands from quite a few ...

Like a lot of singers, Piper Rockelle has a link at the top of her TikTok profile page where her over 8 million followers can check out her music. But instead of sending them to YouTube or Spotify, ...

SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the fourth quarter and full year ...